This study investigated whether the selective 5HT(1F) receptor agonist LY33
4370 has other possible antimigraine mechanisms in addition to the proposed
inhibition of dural plasma extravasation. LY334370 (up to 10(-5) M) had no
vasoconstrictor effects on human cerebral arteries in vitro. It had no eff
ect (up to 10 mg kg(-1), iv) on neurogenic vasodilation of dural blood vess
els produced by electrical stimulation of the dura mater in anesthetized ra
ts. Nor had it any effect (at 3 mg kg(-1), iv) on the hyperalgesia produced
by injection of carrageenan into the paw of conscious rats or on nocicepti
ve reflex responses in the spinalized, decerebrate rabbit (up to 3 mg kg-l,
iv), indicating that it has no general analgesic properties. However, it s
ignificantly inhibited activation of second-order neurons in the trigeminal
nucleus caudalis produced by electrical stimulation of the dura mater in a
nesthetised rats at 3 mg kg(-1), iv. These results provide evidence to sugg
est that LY334370 has a central mechanism of action in blocking the transmi
ssion of nociceptive impulses within the trigeminal nucleus caudalis and th
at this may represent a mechanism through which it has its antimigraine eff
ect.